|
09/12/2011 |
|
HemaQuest
Pharmaceuticals
Completes Patient
Enrollment in Phase 2
Clinical Study of
HQK-1001 in Patients
With Sickle Cell Disease |
|
HemaQuest Press Release |
|
more |
|
09/06/2011 |
|
Syndax Pharmaceutical’s
Positive Phase 2 Data
Supports Potential for
Entinostat in Advanced
Breast Cancer |
|
Syndax Press Release |
|
more |
|
08/17/2011 |
|
Syndax Pharmaceuticals
Announces Issuance of EU
Patent for Entinostat |
|
Syndax Press Release |
|
more |
|
06/16/2011 |
|
Tioga Pharmaceuticals
Issued Key U.S. Patent
for the Use of
Asimadoline to Treat
D-IBS |
|
Tioga Press Release |
|
more |
|
06/08/2011 |
|
Syndax Pharmaceuticals
Elects Arlene Morris to
Board of Directors |
|
Syndax Press Release |
|
more |
|
06/02/2011 |
|
Syndax Pharmaceuticals
Announces Issuance of US
Patent for Entinostat |
|
Syndax Press Release |
|
more |
|
06/01/2011 |
|
FDA Grants Fast Track
Designation to Tioga
Pharmaceuticals’
Asimadoline for the
Treatment of
Diarrhea-Predominant
Irritable Bowel Syndrome |
|
Tioga Press Release |
|
more |
|
05/02/2011 |
|
Affinium
Pharmaceuticals, Ltd.,
Announces Results of
AFN-1252 Multiple
Ascending Dose Phase I
Clinical Trial |
|
Affinium Press Release |
|
more |
|
04/25/2011 |
|
HemaQuest
Pharmaceuticals
Announces First Patient
Enrolled in Phase 2
Clinical Study of
HQK-1001 in Patients
With Sickle Cell Disease |
|
HemaQuest Press Release |
|
more |
|
03/31/2011 |
|
Syndax Pharmaceuticals
Announces Entinostat
Data at 102nd Annual
American Association for
Cancer Research Meeting |
|
Syndax Press Release |
|
more |
|
03/01/2011 |
|
Syndax Announces Start
Of NCI Sponsored Phase 2
Study Of Entinostat In
Combination In Triple
Negative Breast Cancer |
|
Syndax Press Release |
|
more |
|
12/09/2010 |
|
Syndax Pharmaceuticals’
Entinostat Plus
Erlotinib Improves
Survival in Select NSCLC
Patients |
|
Syndax Press Release |
|
more |
|
12/07/2010 |
|
HemaQuest
Pharmaceuticals, Inc.
Presents Promising
Clinical Results at 52nd
Annual Meeting of the
American Society of
Hematology (ASH) |
|
HemaQuest Press Release |
|
more |
|
12/03/2010 |
|
HemaQuest Announces
Appointment of New
Executive Management
Team, Company
Establishes Headquarters
in San Diego |
|
HemaQuest Press Release |
|
more |
|
10/25/2010 |
|
Essentialis Receives
Special Protocol
Assessment Agreement
from the FDA for Phase 3
Trial of DCCR |
|
Essentialis Press Release |
|
more |
|
10/12/2010 |
|
Affinium
Pharmaceuticals, Ltd.
Announces the Initiation
of an Oral,
Multiple-Ascending-Dose
Phase I Clinical Trial
of AFN-1252, its Novel
Anti-staphylococcal
Antibiotic |
|
Affinium Press Release |
|
more |
|
08/11/2010 |
|
HemaQuest
Pharmaceuticals
Initiates Phase 2
Clinical Trial in
EBV‐Related Malignancies |
|
HemaQuest Press Release |
|
more |
|
08/05/2010 |
|
HemaQuest
Pharmaceuticals
Initiates Phase 2
Clinical Trial in
EBV-Related Malignancies |
|
HemaQuest Press Release |
|
more |
|
07/28/2010 |
|
Sainsbury’s Becomes
First UK Retailer to
Install Asteres 24/7
Automated Pharmacy
Kiosks |
|
Asteres Press Release |
|
more |
|
07/28/2010 |
|
HemaQuest
Pharmaceuticals Raises
Additional $4M to Bring
Total to $16M in Series
B Financing |
|
HemaQuest Press Release |
|
more |
|
06/30/2010 |
|
Sanofi-aventis To
Acquire TargeGen, Inc |
|
TargeGen Press Release |
|
more |
|
06/04/2010 |
|
Syndax Pharmaceuticals’
Entinostat Shows
Clinical Promise in
Patients with Advanced
Hormone Refractory
Breast Cancer |
|
Syndax Press Release |
|
more |
|
06/03/2010 |
|
Tioga Pharmaceuticals
Begins Phase 3 Trial of
Asimadoline in Irritable
Bowel Syndrome |
|
Tioga Press Release |
|
more |
|
05/24/2010 |
|
Syndax Pharmaceuticals
Inc. to Present
Entinostat Data Showing
Benefit in Combination
in Advanced Breast
Cancer at ASCO |
|
Syndax Press Release |
|
more |
|
04/09/2010 |
|
Affinium
Pharmaceuticals, Ltd.
Announces the Initiation
of a Phase I Clinical
Trial Using an Optimized
Oral Formulation of
AFN-1252, its Novel
Anti-staphylococcal
Antibiotic |
|
Affinium Press
Release |
|
more |
|
04/05/2010 |
|
Tioga Pharmaceuticals
Receives Special
Protocol Assessment
Agreement from FDA for
Phase 3 Trials of
Asimadoline in Irritable
Bowel Syndrome |
|
Tioga Press Release |
|
more |
|
03/11/2010 |
|
China's WuXi, a Partner
of San Diego's TargeGen,
Offers New Model for
Drug Development |
|
X-Conomy.com |
|
more |
|
03/31/2010 |
|
Syndax Pharmaceuticals
Announces Entinostat
Data at 102nd Annual
American Association for
Cancer Research Meeting |
|
Syndax Press Release |
|
more |
|
02/17/2010 |
|
Tioga Pharmaceuticals,
Inc. Raises $18 Million
to Fund Phase 3 Clinical
Trial in Irritable Bowel
Syndrome |
|
Tioga Press Release |
|
more |
|
12/21/2009 |
|
Biotech company has
survival skills: Ambit
Biosciences overcomes
challenges, now has new
partner |
|
San Diego Union
Tribune |
|
more |
|
12/18/2009 |
|
Ambit Biosciences And
Astellas Enter Strategic
Partnership To Research,
Develop And
Commercialize Flt3
Kinase Inhibitors In
Multiple Indications |
|
Ambit Biosciences Press Release |
|
more |
|
12/11/2009 |
|
Ambit Biosciences
Initiates First Phase 2
Clinical Trial Of Ac220
In Acute Myeloid
Leukemia |
|
Ambit Biosciences Press Release |
|
more |
|
12/8/2009 |
|
HemaQuest
Pharmaceuticals Presents
Promising Results in
Sickle Cell Disease and
Beta Thalassemia |
|
HemaQuest Press Release |
|
more |
|
12/7/2009 |
|
Ambit Biosciences
Corporation Presents
Phase I Clinical Results
Of Ac220 In Patients
With Acute Myeloid
Leukemia At Ash
Conference |
|
Ambit Biosciences Press Release |
|
more |
|
11/23/2009 |
|
Nereus Pharmaceuticals
Presents Positive
Interim Data from the
ADVANCE study, A
Randomized Phase 2
Clinical Trial of
Plinabulin (NPI-2358) in
Non-Small Cell Lung
Cancer at the 2009
EORTC-NCI-AACR
Conference |
|
Nereus Press Release |
|
more |
| 10/22/2009 |
| TargeGen
Announces Successful
Completion of Clinical Trial
of JAK2 Inhibitor TG101348
in Myelofibrosis Patients |
| TargeGen Press Release |
|
more |
|
9/18/2009 |
|
NovoStent Announces
Completion of Enrollment
in SAMBA Femoropopliteal
Trial |
|
NovoStent Press Release |
|
more |
|
9/1/2009 |
|
Tioga Pharmaceuticals,
Inc. and Ono
Pharmaceutical Co.
Announce Agreement to
Develop and
Commercialize
Asimadoline in Japan |
|
Tioga Press Release |
|
more |
|
8/18/2009 |
|
Fine-tuning an
anti-cancer drug |
|
Nereus Press Release |
|
more |
|
8/11/2009 |
|
Essentialis To Submit
Spa For
Hypertriglyceridemia |
|
Essentialis Press Release |
|
more |
|
8/5/2009 |
|
Asteres Inc. Names
Retail Veteran Jim
Mastrian to Board of
Directors |
|
Asteres Press Release |
|
more |
|
8/4/2009 |
|
Asteres Inc. Debuts
ScriptCenter 24/7
Automated Pharmacy
Services |
|
Asteres Press Release |
|
more |
|
6/9/2009 |
|
Asteres Inc. Expands
Markets and Management
naming Mark de Bruin,
CEO |
|
Asteres Press Release |
|
more |
|
6/3/2009 |
|
Asteres Inc. Announces
Hansen Retirement |
|
Asteres Press Release |
|
more |
|
5/26/2009 |
|
HemaQuest Initiates
Clinical Trials in
Sickle Cell Disease and
Beta Thalassemia |
|
HemaQuest Press Release |
|
more |
|
5/18/2009 |
|
Essentialis Meets
Primary Endpoint In
Phase 2b Trial Of DCCR
For Treatment Of
Hypertriglyceridemia And
Is Granted Extensive
Patent Coverage In The
US |
|
Essentialis Press Release |
|
more |
| 5/14/2009 |
| TargeGen
Announces Successful
Completion of Patient
Enrollment In Clinical Trial
of JAK2 Inhibitor TG101348
in Myelofibrosis Patients
And Scheduled Presentation
of Preliminary Trial Data At
EHA Conference in Berlin |
| TargeGen Press Release |
|
more |
|
3/25/2009 |
|
HemaQuest
Pharmaceuticals Receives
European Orphan
Medicinal Product
Designations for
Therapeutic to Treat
Hemoglobin Disorders |
|
HemaQuest Press Release |
|
more |
|
3/23/2009 |
|
Nereus Pharmaceuticals
Initiates ADVANCE, A
Randomized Phase 2
Clinical Trial of
NPI-2358 in Non-Small
Cell Lung Cancer |
|
Nereus Press Release |
|
more |